Christophe Pierre Weber
President and CEO at Takeda Pharmaceutical Company Limited
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 1 year
- Director since
- 2026
1 year of board service in total across 2 boards, counting each seat separately. Longest: Boston Scientific Corporation, 8 months.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Boston Scientific Corporation April 30, 202699.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 7, 2026 | Boston Scientific Corporation | Grant or award | +1,767 | — | — |
| May 7, 2026 | Boston Scientific Corporation | Grant or award | +1,140 | — | — |
| Apr 27, 2026 | Takeda Pharmaceutical Company Limited | Grant or award | +78,900 | — | — |
| Apr 27, 2026 | Takeda Pharmaceutical Company Limited | Grant or award | +165,370 | — | — |
| Mar 2, 2026 | Boston Scientific Corporation | Grant or award | +556 | — | — |
| Mar 2, 2026 | Boston Scientific Corporation | Grant or award | +323 | — | — |
Questions about Christophe Pierre Weber
What boards is Christophe Pierre Weber on?
Christophe Pierre Weber sits on the boards of Boston Scientific Corporation and Takeda Pharmaceutical Company Limited.
What company is Christophe Pierre Weber the CEO of?
Christophe Pierre Weber has been President and CEO of Takeda Pharmaceutical Company Limited since March 2026.
How long has Christophe Pierre Weber served on boards?
Our records show at least 1 year of board service across 2 boards, the earliest from 2026.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.